Central AsianResearch Index

Harmonization of Preclinical and Clinical Studies within the Framework of the Global WHO "One Health" Concept through the Implementation of Agreed Standards for Biosafety and Medical Technologies

Гармонизация доклинических и клинических исследований в рамках глобальной концепции ВОЗ «Единое здоровье» посредством имплементации согласованных стандартов биологической безопасности и медицинских технологий

The article examines regulatory and methodological approaches to the harmonization of preclinical and clinical trials within the CIS region under the paradigm of the World Health Organization’s (WHO) global "One Health" concept. The authors substantiate the necessity of shifting from isolated biosafety assessments to proactive, cross-sectoral regulation. This approach integrates a three-tier biosafety framework (comprising veterinary medicines and feed additives; pesticides and agrochemicals; dietary supplements, as well as perfumery, cosmetic, and food products) with the advanced sector of high-tech medical technologies. The development of methodological guidelines for CIS countries transforms the system of preclinical and clinical trials from a highly specialized pharmaceutical market tool into a fundamental element of proactive response and public health protection, aligned with the global WHO agenda. Concurrently, pairing the end-to-end sanitary control of the "biological shield" with cutting-edge digital Research & Development (R&D) technologies turns the Eurasian space into an investment-attractive, commercially successful, and technologically independent hub. This guarantees high safety standards for the end consumer across all levels: from the environmental and food chains (control of pesticides, agrochemicals, veterinary medicines, and feed additives) to everyday consumer goods (dietary supplements, perfumery, cosmetics, and food products). Such an integrated approach directly translates into a significant improvement in the quality and safety of patients' lives. This includes both increasing the availability of classic medicines and medical devices, and accelerating the market launch of next-generation pharmaceutical innovations.

Сведения

Опубликовано
2026 · Т. 61, № 3, С. jhd070-jhd070
Язык
Английский
ISSN
2663-1768 · 2663-1776 · 2225-9929
Издатель
Salidat Kairbekova National Research Center for Health Development
Аффилиации
CIS Interparliamentary Assembly